With the development of science and technology, the excellent properties of more polymer materials have been continuously explored. COP vial is a typical representative of new materials used in the field of pharmaceutical packaging.
COP vial is suitable for anti-cancer, anti-tumor, rheumatic, protein and other high value-added drugs.
COP vial has high transparency, low birefringence, low water absorption, high rigidity, high heat resistance, low protein adsorption, good water vapor airtightness, can be stored in liquid nitrogen, and meets FDA standards. According to incomplete statistics, the list of medicines suitable for COP vials is as follows:
Avastin (bevacizumab), Herceptin (trastuzumab for injection), adalimumab (Humira), Palivizumab alias Palivizumab, Anthrax (disease) , combined with chlorambucil, belimumab, treatment of systemic lupus erythematosus, alemtuzumab, certolizumab, trastuzumab, transtuzumab <anti-tumor drug>, diabetes, rani Bulimumab Injection, Opdivo, Pertuzumab, Golimumab, Panitumumab, Primumab, Erbitux, Infliximab, Rituximab ( Rituxan), etanercept, darbepoetin alfa, interferon beta-1b, rituximab <anti-tumor drug>, interferon beta-1a, nulasta, aflibercept, gonadotropin Hormones, anakinra <interleukin receptor blocker>, and pegaspargase injection.
The above is a list of known drugs suitable for COP vial packaging on the market. With the continuous advancement of technology in the pharmaceutical industry, more new drugs will continue to come out, and the scope of application of COP vials will be more common.
没有评论:
发表评论